Cresset, an innovative provider of solutions for Computational Drug Discovery and Development, is expanding its existing Asia Pacific presence by creating a new headquarters (HQ) in Bengaluru.

This announcement consolidates Cresset’s position as a global player in the drug discovery space, and comes off the back of establishing a new facility in Boston earlier in the year.

From its origins in the UK, Cresset has grown into a drug discovery solutions company with a genuine global reach, with more than 60% of its revenues now coming from outside the UK. The company has experienced rapid growth in recent years, achieving an average year-on-year growth of over 25% and a significant increase in its employee headcount since 2020.

Cresset’s new India site will support the growing demands of Cresset’s APAC customer base, and increase its reach in a range of markets across the region, including South Korea, Japan, China, and Australasia.

Commenting on the new Indian HQ Cresset’s Chief Scientific Officer and co-Founder Dr. Mark Mackey said “Launching our new site in India marks a major milestone in our international growth and expansion as a company. The talent pool and centers of excellence available in the region will enable us to expand our existing service offering to clients and develop strong relationships through face-to-face contact on the ground.

“We already have a satellite office space in Bangalore, where a high proportion of our Indian staff are currently based. The new office will allow us to grow our overall business and gain access to grant funding in the Indian market”